Issue link: http://osercommunicationsgroup.uberflip.com/i/1013207
Chain Drugstore Daily Monday, August 27, 2018 1 8 Understanding Cognitive Health with FOCUSfactor An interview with Jack Ross, Chief Executive Officer, Synergy CHC Corp. CDD: Can you describe FOCUSfactor for our readers? JR: FOCUSfactor is a brain health sup- plement that contains a patented blend of vitamins, minerals, antioxidants and neuro-nutrients. In fact, FOCUSfactor packs so much nutrition into its patented formula, it could actually take the place of your current multi-vitamin. CDD: What makes FOCUSfactor unique in the brain health category? JR: Unlike most brain health supple- ments, FOCUSfactor has been clinically tested using a randomized, double-blind- ed, placebo-controlled study resulting in significant improvement in memory, con- centration and focus. CDD: Who conducted the clinical study for FOCUSfactor and how was it differ- ent from other studies? JR: The study was conducted by Cognitive Research Corporation, a lead- ing clinical research organization in August of 2011 under the guidelines and protocol of the Institutional Review Board (IRB) with leading cognition experts overseeing the study. FOCUSfactor may be the first brand to actually conduct a cognitive clinical study on a healthy population using a fin- ished goods, multi-ingredient formula- tion as opposed to a single-ingredient study. CDD: Can you provide some insight into the clinical and some of the key findings? JR: The clinical set out to measure changes in memory, concentration, atten- tion and focus, which ran for a period of six weeks. The results showed that healthy adults who followed the study protocol showed significant improve- ment in memory, concentration and focus. The effects were partic- ularly pronounced in what we call 'verbal learning and short- term memory.' Specifically, one of the test results showed a significant improvement in recall of 44 percent from 4.5 words (in the placebo group) versus 6.5 words (in the FOCUSfactor group). CDD: Can you tell our readers about your marketing plans? JR: Our plans are to drive awareness and trial behind FOCUSfactor leveraging its unique set of cognitive benefits. We have entered into a multi- year licensing agreement to use Albert Einstein's name and likeness for our advertising campaign called 'Feed Your Einstein.' CDD: What other FOCUSfactor prod- ucts do you offer? JR: The FOCUSfactor family contains a range of innovative cognitive products that provide additional benefits for both adults and kids. FOCUSfactor Extra Strength provides an advanced formula- tion with increased levels of key selected neuro-nutrients. FOCUSfactor Brain & Vision combines the original formula with clinically tested levels of lutein and zeaxanthin for improved eye-support creating a 2-in-1 formula. FOCUSfactor for Kids has been specifically designed for kids with vitamins and neuro-nutrients to help sup- port healthy brain function. The product comes in a great tasting berry blast chewable and con- tains no artificial colors, flavors or preservatives and is gluten- and dairy- free. CDD: What are your thoughts on the future of the brain health category? JR: According to various studies from the NIH and CDC, brain health is consid- ered one of the top age-related concern among baby boomers. As a result, we anticipate continued double-digit growth in the brain health category over the next three to five years. For more information, contact Gail Lane at gail@synergychc.com. Natural Solutions: Berry Sleepy and Berry Awake By James Lacey, Chief Executive Officer As the Chief Executive Officer of Berry Sleepy, my nine years of starting and run- ning Crunchies Natural Freeze Dried brings a unique transferable skill set of running all disciplines from manufactur- ing to retail execution. My entrepreneur- ial and large company executive experi- ence brings both innovation and structure to up-and-coming small to midsize com- panies and brands. In 2014, Greg Doring and his wife, Adrienne, couldn't sleep with the rapid expansion of their family and work-relat- ed activities. They took it upon them- selves to come up with a solution and created Berry Sleepy, an innovative and healthy way to sleep without the side effects of prescription and over the counter medications. Tim Prier then joined the company for the same reason the as the Dorings. After setting up the foundation, Tim and Greg added me to their team because I was looking for sleeping solutions that were natural like Berry Sleepy. At Natural Products West, my team and I upgraded the formula of the berry-based sleep aid and added three new delivery systems, including a liquid shot. During our research over the last year, we saw the same need in the energy category as we witnessed in the sleep cat- egory. The research results were over- whelmingly in favor of a natural product that had the same efficiency and perform- ance as the unhealthy energy products on the market today. We found that 60 per- cent of consumers would purchase the new Berry Awake shot if it were avail- able. Berry Sleepy is made up of a pro- prietary sleep and relaxation blend of all-natural tart cher- ries, passion fruit, goji berries and valerian root extract. The base of this formula is all berries, with prebiotics to aid in replacing and healing cells in the digestive tract. Berry Awake, the natural energy shot, is made up of a proprietary energy blend of green coffee berries extract, guarana seed extract, bacopa leaf extract and ginseng. In addition, we added 2,000 mg of pea protein to aid your energy boost for the day. All Berry Sleepy and Berry Awake products are kosher, non-GMO, vegan and made in the USA. We will be fea- tured on "Modern Living with Kathy Ireland," which will be aired globally. Berry Sleepy and Berry Awake represent a unique opportunity from Baby Boomers to Millennials. As most aging Baby Boomers have noticed, snoring and lack of sleep are associated with the development of chronic diseases, linked to fami- ly stresses and pressure in the work environ- ment. Berry Sleepy's natural ingredients provide the consumer with high-quality sleep aid with no side effects. We are pro- viding this product in veg caps and liquid shots, all easy delivery methods. Millennial consumers are looking for a healthy, natural alternative to energy- boosting products that they can consume daily. Millennials have driven the coffee and energy segment into high-growth categories, but they are looking for natu- ral products that have the effect of coffee and energy products without the side effects. We can provide this with great- tasting Berry Awake. For more information, visit booth #1042. Amneal: Accelerating Growth from All Angles The new Amneal is now among the lead- ing generic pharmaceutical companies in the United States. The increased scale and product diversification, along with a growing specialty franchise, positions Amneal for continued growth. That growth will be driven, in part, by an increasing commitment to R&D resources, ensuring the ongoing develop- ment of important and value-generating products within the Generic and Specialty Pharma divisions. Amneal's R&D strate- gy is led by a deeply accomplished in- house development team and supplement- ed by creative product development part- nerships with external stakeholders. In the Generics business, Amneal is increasing its focus on complex solid oral and alternative dosage form Abbreviated New Drug Applications (ANDAs) with high-value, difficult to develop, first-to- file or first-to-market product opportuni- ties. The company's development capa- bilities are industry-leading and span all dosage forms, including complex oral solids, injectables, ophthalmics, liquids, topicals and transdermals. The Amneal Generics pipeline is currently one of the industry's largest, including more than 280 products filed with the FDA or in development. This pipeline includes products across a broad range of therapeutic areas including car- diovascular, central nervous system/pain, oncology, inflammation, anti-infective, dermatology, endocrinology, diabetes, rhi- nology, urology and hema- tology, among others. At the end of June, Amneal had already received 16 ANDA approvals with 13 new generic product launches under its belt. At the time of writing, several more launches were on track for July and August. Amneal's growing Specialty busi- ness now includes Impax's marketed products in central nervous system disor- ders and parasitic infections as well as Gemini's marketed products in endocrinology and other therapeutic cat- egories. Furthermore, Amneal has three biosimilar products in various stages of development as it continues to evolve and diversify its business. While Amneal has certainly grown from its founding as a family-run start-up in 2002, the compa- ny remains focused on the original prin- ciples that have guided its success for nearly two decades. Family values of ethics and integrity are central to Amneal's culture, mission and future. Whether delivering affordable medi- cines through its generics business, meet- ing important medical needs through its Specialty brands division or partnering with doctors, customers and other stake- holders to provide solutions for tomorrow's health challenges, Amneal is more deter- mined than ever to make healthy possible. For more information, visit booth #110, go to www.amneal.com, call 866.525.7270 or email sales@amneal.com.